The V Foundation Translational grant supports Dr. Wechsler-Reya's innovative research in identifying new targets and potential therapies for pediatric brain tumors.
Ben Izar, MD, PhD, joins this cohort with an award of $1.25 million to continue the transformative work in his lab to enhance T cell function in cancer immunotherapy.
Four Columbia University faculty members have been named as 2024 Velocity Fellows and awarded pilot grants to support their early-stage cancer research.
The HICCC is pleased to announce a fifth Irving Cancer Drug Discovery Program (ICDDP) project, designed to help faculty accelerate cancer research discoveries.
Twelve research teams led by Columbia faculty, across diverse disciplines, have been awarded a Columbia Life Science Accelerator pilot grant for their inventive lab-to-market projects.
Dr. Dawn Hershman recognized with 2021 Mentor of the Year Award, an annual award bestowed by Columbia University Irving Medical Center and the Irving Institute for Clinical and Translational Research.
Congratulations to the 2021 recipients of Conquer Cancer/ASCO awards for young investigators who are working on innovative research projects aimed at advancing cancer care and treatment.